TREAT Asia Pediatric HIV Observational Database (TApHOD)
As of 2024, TApHOD, includes over 7,500 human immunodeficiency virus (HIV)-infected participants from six low and middle-income countries of Cambodia, India, Indonesia, Malaysia, Thailand, and Vietnam. The study aims to examine the causation of HIV, and monitor the success of antiretroviral therapy (ART), in improving the management of children living with HIV within the region. Participants are followed up as part of routine patient care at clinical sites, with a median follow-up duration of 3 years. The cohort consists of children aged 18 years or younger, with a median age of 7 years at the start of ART.
Study design
Cohort - clinical
Number of participants at first data collection
2,280 (participants)
Recruitment is ongoing
Age at first data collection
0 - 17 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Countries
Year of first data collection
2007
Primary Institutions
University of New South Wales (UNSW)
Profile paper DOI
Funders
The Foundation for AIDS Research (amFAR)
Austrian AIDS Life Asoociation
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institutes of Health (NIH)
Ongoing?
Yes
Data types collected
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Secondary data
- Self-report questionnaire – unspecified
- None
- None
- Healthcare data
- Mortality data
Engagement
Keywords
